Developing novel protein therapeutics for healthcare
Explore our technology
Get Involved
TRIM-edicine is an early-stage, privately held biotechnology company engaged in the development of novel biopharmaceutical products for the treatment of several important unmet medical needs.
Message from the Founder
At TRIM-edicine, we focus on developing innovative treatments to patients with unmet medical needs such as tissue injury, muscular dystrophy, cancer, and diabetes. Our world class scientists have partnered with major pharmaceutical companies as we progress towards our goal of bringing novel therapeutics to patients. We welcome your interest in our company.
Sincerely,
Jianjie Ma
Founder and President
Recent News
- January 13, 2012
TRIM-edicine was awarded US Patent #7,981,866, on MG53 compositions and methods of use
- May 12, 2011